Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03179800 · ClinicalTrials.gov registry record · NA
CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
A NA study of Hypertension and Resistant Hypertension, sponsored by Vascular Dynamics.
- Active
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 6
- Study locations
NCT03179800: Active NA study of Hypertension and Resistant Hypertension, sponsored by Vascular Dynamics.
NCT03179800 is a NA study of Hypertension and Resistant Hypertension that is active but no longer recruiting, run by Vascular Dynamics. The registered enrollment target is 300 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03179800, a NA study of Hypertension and Resistant Hypertension, is active but no longer recruiting, sponsored by Vascular Dynamics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 6
- Study locations
Study Summary
The objective of this study is to evaluate the safety and effectiveness of the MobiusHD System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal study.
Conditions Studied
Interventions
- DEVICE MobiusHD
- OTHER Sham Implantation
Study Locations (6)
Georgia
- Emory University Hospital Midtown - Atlanta
Illinois
- Southern Illinois University - Springfield
Indiana
- St. Vincent Heart Center of Indiana - Indianapolis
Louisiana
- Ochsner Medical Center - New Orleans
Ohio
- The Carl & Edyth Lindner Center for Research & Education at The Christ Hospital - Cincinnati
Other
- CHU Nancy Centre Coeur et Vaisseaux - Nancy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2017-10-19 |
| Est. Completion | 2025-05 |
| Phase | NA |
What the registry record for NCT03179800 still lists
NCT03179800 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which MobiusHD is the first listed.
NCT03179800 lists 6 locations in 6 states (Georgia, Illinois, Indiana).
Frequently Asked Questions
What is clinical trial NCT03179800 about?
NCT03179800 is a clinical study titled "CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™". The objective of this study is to evaluate the safety and effectiveness of the MobiusHD System in a prospective, randomized, double-blind, sham-controlled multi-center pivotal study.
What is the current status of trial NCT03179800?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2017-10-19. Estimated completion is 2025-05.
What conditions does trial NCT03179800 study?
This clinical trial studies the following conditions: Hypertension, Resistant Hypertension.
What interventions are being tested in trial NCT03179800?
The interventions under investigation include: MobiusHD (DEVICE), Sham Implantation (OTHER).
Who is sponsoring clinical trial NCT03179800?
This trial is sponsored by Vascular Dynamics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03179800 being conducted?
This trial has 6 study locations across Georgia, Illinois, Indiana, Louisiana, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03179800's enrollment target sits among peer trials
300 170th of 470 higher than 291 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI